P49770 (EI2BB_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Translation initiation factor eIF-2B subunit beta Alternative name(s): S20I15 S20III15 eIF-2B GDP-GTP exchange factor subunit beta | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 351 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. |
| Subunit structure | Complex of five different subunits; alpha, beta, gamma, delta and epsilon. |
| Involvement in disease | Leukodystrophy with vanishing white matter (VWM) [MIM:603896]: A leukodystrophy that occurs mainly in children. Neurological signs include progressive cerebellar ataxia, spasticity, inconstant optic atrophy and relatively preserved mental abilities. The disease is chronic-progressive with, in most individuals, additional episodes of rapid deterioration following febrile infections or minor head trauma. While childhood onset is the most common form of the disorder, some severe forms are apparent at birth. A severe, early-onset form seen among the Cree and Chippewayan populations of Quebec and Manitoba is called Cree leukoencephalopathy. Milder forms may not become evident until adolescence or adulthood. Some females with milder forms of the disease who survive to adolescence exhibit ovarian dysfunction. This variant of the disorder is called ovarioleukodystrophy. |
| Sequence similarities | Belongs to the eIF-2B alpha/beta/delta subunits family. |
| Sequence caution | The sequence AAC42002.1 differs from that shown. Reason: Frameshift at several positions. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 351 | 351 | Translation initiation factor eIF-2B subunit beta | PRO_0000156061 | |||||
Natural variations | |||||||||
| Natural variant | 85 | 1 | V → E in VWM. Ref.9 | VAR_068451 | |||||
| Natural variant | 171 | 1 | S → F in VWM; with ovarian failure. Ref.7 Ref.8 | VAR_016842 | |||||
| Natural variant | 196 | 1 | P → S in VWM. Ref.8 | VAR_068452 | |||||
| Natural variant | 200 | 1 | G → V in VWM. Ref.8 | VAR_068453 | |||||
| Natural variant | 213 | 1 | E → G in VWM; with and without ovarian failure. Ref.6 Ref.7 Ref.8 Ref.11 | VAR_012289 | |||||
| Natural variant | 268 | 1 | C → Y in VWM. Ref.10 | VAR_068454 | |||||
| Natural variant | 273 | 1 | K → R in VWM. Ref.6 | VAR_012321 | |||||
| Natural variant | 316 | 1 | V → D in VWM. Ref.6 | VAR_012290 | |||||
| Natural variant | 329 | 1 | G → V in VWM. Ref.6 | VAR_012322 | |||||
Experimental info | |||||||||
| Sequence conflict | 6 | 1 | A → K in AAC42002. Ref.2 | ||||||
| Sequence conflict | 23 | 1 | K → T in AAC42002. Ref.2 | ||||||
| Sequence conflict | 30 | 1 | S → R in AAC42002. Ref.2 | ||||||
| Sequence conflict | 35 | 1 | A → V in AAC42002. Ref.2 | ||||||
| Sequence conflict | 52 | 1 | S → R in AAC42002. Ref.2 | ||||||
| Sequence conflict | 95 – 101 | 7 | RLHGRSD → DSMDAAT in AAC42002. Ref.2 | ||||||
| Sequence conflict | 110 | 1 | H → D in AAC42002. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | Yu W., Sarginson J., Gibbs R.A. Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [2] | "Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease." Sherrington R., Rogaev E.I., Liang Y., Rogaeva E.A., Levesque G., Ikeda M., Chi H., Lin C., Li G., Holman K., Tsuda T., Mar L., Foncin J.-F., Bruni A.C., Montesi M.P., Sorbi S., Rainero I., Pinessi L. St George-Hyslop P.H.Nature 375:754-760(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Brain. |
| [3] | "The DNA sequence and analysis of human chromosome 14." Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., Du H. Weissenbach J.Nature 421:601-607(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Lung. |
| [5] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [6] | "Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter." Leegwater P.A.J., Vermeulen G., Koenst A.A.M., Naidu S., Mulders J., Visser A., Kersbergen P., Mobach D., Fonds D., van Berkel C.G.M., Lemmers R.J.L.F., Frants R.R., Oudejans C.B.M., Schutgens R.B.H., Pronk J.C., van der Knaap M.S. Nat. Genet. 29:383-388(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS VWM GLY-213; ARG-273; ASP-316 AND VAL-329. |
| [7] | "Ovarian failure related to eukaryotic initiation factor 2B mutations." Fogli A., Rodriguez D., Eymard-Pierre E., Bouhour F., Labauge P., Meaney B.F., Zeesman S., Kaneski C.R., Schiffmann R., Boespflug-Tanguy O. Am. J. Hum. Genet. 72:1544-1550(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS VWM PHE-171 AND GLY-213. |
| [8] | "Identification of ten novel mutations in patients with eIF2B-related disorders." Ohlenbusch A., Henneke M., Brockmann K., Goerg M., Hanefeld F., Kohlschutter A., Gartner J. Hum. Mutat. 25:411-411(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS VWM PHE-171; SER-196; VAL-200 AND GLY-213. |
| [9] | "Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5." Matsukawa T., Wang X., Liu R., Wortham N.C., Onuki Y., Kubota A., Hida A., Kowa H., Fukuda Y., Ishiura H., Mitsui J., Takahashi Y., Aoki S., Takizawa S., Shimizu J., Goto J., Proud C.G., Tsuji S. Neurogenetics 12:259-261(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VWM GLU-85. |
| [10] | "Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype." Alsalem A., Shaheen R., Alkuraya F.S. Gene 496:141-143(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VWM TYR-268. |
| [11] | "Vanishing white matter disease: an Italian case with A638G mutation in exon 5 of EIF2B2 gene, an unusual early onset and a long course." Sambati L., Agati R., Bacci A., Bianchi S., Capellari S. Neurol. Sci. 0:0-0(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VWM GLY-213. |
| + | Additional computationally mapped references. |
Web resources
| GeneReviews |
| Mendelian genes eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa (EIF2B2) Leiden Open Variation Database (LOVD) |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF035280 mRNA. Translation: AAB88176.1. L40395 mRNA. Translation: AAC42002.1. Frameshift. AC006530 Genomic DNA. Translation: AAD30183.1. BC011750 mRNA. Translation: AAH11750.1. |
| IPI | IPI00028083. |
| RefSeq | NP_055054.1. NM_014239.3. |
| UniGene | Hs.409137. |
3D structure databases | |
| ProteinModelPortal | P49770. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P49770. 4 interactions. |
| STRING | 9606.ENSP00000266126. |
PTM databases | |
| PhosphoSite | P49770. |
Polymorphism databases | |
| DMDM | 6226858. |
Proteomic databases | |
| PaxDb | P49770. |
| PeptideAtlas | P49770. |
| PRIDE | P49770. |
Protocols and materials databases | |
| DNASU | 8892. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000266126; ENSP00000266126; ENSG00000119718. |
| GeneID | 8892. |
| KEGG | hsa:8892. |
| UCSC | uc001xrc.2. human. |
Organism-specific databases | |
| CTD | 8892. |
| GeneCards | GC14P075469. |
| HGNC | HGNC:3258. EIF2B2. |
| HPA | HPA005841. |
| MIM | 603896. phenotype. 606454. gene. |
| neXtProt | NX_P49770. |
| Orphanet | 99854. Cree leukoencephalopathy. 157716. Late infantile CACH syndrome. 99853. Ovarioleukodystrophy. |
| PharmGKB | PA27689. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG1184. |
| HOGENOM | HOG000208487. |
| HOVERGEN | HBG051458. |
| InParanoid | P49770. |
| KO | K03754. |
| OMA | FVSPHEV. |
| OrthoDB | EOG4JT05R. |
| PhylomeDB | P49770. |
Enzyme and pathway databases | |
| Reactome | REACT_17015. Metabolism of proteins. REACT_71. Gene Expression. |
Gene expression databases | |
| ArrayExpress | P49770. |
| Bgee | P49770. |
| CleanEx | HS_EIF2B2. |
| Genevestigator | P49770. |
| GermOnline | ENSG00000119718. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000649. IF-2B-related. [Graphical view] |
| PANTHER | PTHR10233. PTHR10233. 1 hit. |
| Pfam | PF01008. IF-2B. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 8892. |
| NextBio | 33395. |
| SOURCE | Search... |
Entry information
| Entry name | EI2BB_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P49770 Secondary accession number(s): O43201 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 14 Human chromosome 14: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
